Vaccini prodotti a Anagni: la società Catalent rinuncia e trasloca in Inghilterra- Corriere.it
Azioni USA: Johnson & Johnson pattern rialzista, Catalent in rialzo del 54% nel 2023 - fxempire.it
White House knew more than a week ago of J&J contractor vaccine-supply problems - POLITICO
Anagni – Alla Catalent dopo Astrazeneca anche Pfizer – BioNTech e Johnson & Johnson | TG24.info
Catalent to Expand Production of J&J Covid-19 Vaccine in Italy - WSJ
Catalent Distributing Johnson & Johnson Vaccine | news - Indiana Public Media
Johnson & Johnson vaccine production problems at Emergent plant in Baltimore - The Washington Post
Catalent increases capacity for J&J's COVID vaccine - BioProcess InsiderBioProcess International
Brad Johnson - Associate Director, Operations (Projects/Support) - Catalent Pharma Solutions | LinkedIn
Anagni, in fumo il progetto da 100 milioni di Catalent per la produzione di vaccini - AboutPharma
The Story of the Johnson & Johnson COVID-19 Vaccine
Catalent to ramp up J&J vaccine production at Italian plant | Reuters
Catalent Signs Agreement with Johnson & Johnson for COVID-19 Vaccine Candidate
J&J plant authorization clears way for big boost in U.S. COVID-19 shots | Reuters
Addio Catalent a Anagni, "burocrazia troppo lunga ci spostiamo in Gb". Persi 100 posti di lavoro - la Repubblica
Johnson & Johnson Partnering With Bloomington Company To Help Make COVID-19 Vaccine | WBIW
Johnson&Johnson - Fare carriera in Italia? Ecco le 25 aziende che offrono più possibilità (secondo Linkedin) - Corriere.it
Ho visitato oggi l'azienda Catalent di... - Roberto Speranza | Facebook
Johnson & Johnson arriverà ad aprile in Europa. Ecco come funziona
Making and Manufacturing Johnson & Johnson's Janssen COVID-19 Vaccine
Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed | CNN
Catalent breaks ground at US$112m drug product manufacturing facility
Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week : NPR
